Castration Resistant Prostate Adenocarcinoma

general

A prostate adenocarcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production.

47

Centers

64

Active Trials

$11.7B

Cancer Funding

Specific Cancer Types(2)

Top Centers for Castration Resistant Prostate Adenocarcinoma(47)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
66.7
2
NCI Comprehensive
Active Research Program
63.3
3
Active Research Program
60.0
4
Active Research Program
56.7
5
NCI Clinical
Active Research Program
53.3
6
Active Research Program
50.0
7
NCI Comprehensive
8
9
NCI Comprehensive
10
NCI Comprehensive
11
12
NCI Comprehensive
13
NCI Comprehensive
14
NCI Comprehensive
15
NCI Comprehensive
16
NCI Comprehensive
17
NCI Comprehensive
18
19
NCI Comprehensive
20
NCI Comprehensive
21
NCI Comprehensive
22
NCI Comprehensive
23
NCI Comprehensive
24
NCI Clinical
25
NCI Comprehensive
26
NCI Comprehensive
27
NCI Comprehensive
28
29
NCI Comprehensive
30
NCI Clinical
31
32
NCI Comprehensive
33
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
34
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
35
36
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
37
38
NCI Comprehensive
39
40
41
42
43
44
45
BC CancerVancouver, BC
46
47

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →